Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma
© McGovern et al; licensee BioMed Central Ltd. 2010
Received: 26 February 2010
Accepted: 6 October 2010
Published: 6 October 2010
Exposure to chlorine (Cl2) causes airway injury, characterized by oxidative damage, an influx of inflammatory cells and airway hyperresponsiveness. We hypothesized that Cl2-induced airway injury may be attenuated by antioxidant treatment, even after the initial injury.
Balb/C mice were exposed to Cl2 gas (100 ppm) for 5 mins, an exposure that was established to alter airway function with minimal histological disruption of the epithelium. Twenty-four hours after exposure to Cl2, airway responsiveness to aerosolized methacholine (MCh) was measured. Bronchoalveolar lavage (BAL) was performed to determine inflammatory cell profiles, total protein, and glutathione levels. Dimethylthiourea (DMTU;100 mg/kg) was administered one hour before or one hour following Cl2 exposure.
Mice exposed to Cl2 had airway hyperresponsiveness to MCh compared to control animals pre-treated and post-treated with DMTU. Total cell counts in BAL fluid were elevated by Cl2 exposure and were not affected by DMTU treatment. However, DMTU-treated mice had lower protein levels in the BAL than the Cl2-only treated animals. 4-Hydroxynonenal analysis showed that DMTU given pre- or post-Cl2 prevented lipid peroxidation in the lung. Following Cl2 exposure glutathione (GSH) was elevated immediately following exposure both in BAL cells and in fluid and this change was prevented by DMTU. GSSG was depleted in Cl2 exposed mice at later time points. However, the GSH/GSSG ratio remained high in chlorine exposed mice, an effect attenuated by DMTU.
Our data show that the anti-oxidant DMTU is effective in attenuating Cl2 induced increase in airway responsiveness, inflammation and biomarkers of oxidative stress.
Respiratory health is adversely affected by exposure to strong irritant substances such as chlorine (Cl2) or ozone . A single, acute exposure of persons to Cl2 in an industrial or domestic context may trigger asthma in a proportion of those exposed and is termed irritant-induced asthma [2, 3]. High dose exposures may lead to acute lung injury and death . Although the mechanism of the induction of asthma by irritants is uncertain, this form of asthma may be a significant contributor to the current rising prevalence of this disease. Some of the irritants that induce symptoms of asthma such as ozone and Cl2 cause oxidant injury, in particular to the airway epithelium. Desquamation of the airway epithelium and prolonged sub-epithelial inflammation accompanied by airway hyperresponsiveness has been documented following a single acute Cl2 inhalational exposure . Epithelial shedding may adversely affect barrier function of the epithelium and may diminish the influence of epithelial-derived bronchodilator substances such as nitric oxide . Cl2 is a highly reactive substance and has been documented to cause airway injury in mice that is associated with oxidant stress, as evidenced by the finding of peroxynitrite in the airway tissues and carbonylation of proteins . There may be additional contributions to oxidant injury through activation of inflammatory cells . The causative role of oxidative stress in the changes in airway function and airway inflammation caused by a potent oxidant like Cl2 is relatively under-investigated. Recently a combination of anti-oxidants (ascorbic acid, desferroxamine and N-acetylcysteine) was found to attenuate signs of respiratory dysfunction, in particular gas exchange and microvascular leak, in the rat .
The current study was designed to examine the relationship between oxidant damage, airway hyperresponsiveness and inflammation caused by Cl2 by testing the efficacy of an anti-oxidant in protecting against these effects. For this purpose we used dimethylthiourea (DMTU), an oxygen metabolite scavenger , that is highly cell-permeable [11–13]. We also wished to examine the effects of Cl2 on markers of oxidative stress and whether DMTU attenuated these effects. We hypothesized that treatment with DMTU would ameliorate the inflammatory and pathophysiological effects induced by Cl2 gas exposure whether administered before or after exposure.
Animals and protocol
Male Balb/C mice (18-22 g) were purchased from Charles River (Wilmington, Massachusetts) and housed in a conventional animal facility at McGill University. Animals were treated according to guidelines of the Canadian Council for Animal Care and protocols were approved by the Animal Care Committee of McGill University.
Mice were exposed to either room air (control) or Cl2 gas diluted in room air for 5 minutes using a nose-only exposure chamber. An initial experiment was performed to assess an exposure level required to effect changes in airway responsiveness to methacholine (MCh) that was well tolerated by the animals. For this purpose we exposed mice to 100, 200 or 400 ppm Cl2, and 24 hours later we performed MCh challenge and removed the lungs for histological analysis. Based on the results of this experiment we tested the effects of DMTU on animals exposed to 100 ppm Cl2. The control mice were exposed to room air (Control; n = 6) and test mice were exposed to Cl2 (Cl2; 100 ppm; n = 6) with DMTU (100 mg/kg) treatment intraperitoneally either one hour before (DMTU/Cl2; n = 6) or one hour after Cl2 exposure (Cl2/DMTU; n = 6). DMTU was prepared fresh prior to each exposure and a dose of 100 mg/kg in 500 μL of sterile phosphate buffered saline (PBS) was administered i.p. either one hour before or one hour following exposure to Cl2. Control (air exposed) mice received 500 μL PBS i.p and Cl2 exposed mice received 500 μL PBS i.p. either one hour before or one hour following exposure. We chose the dose of DMTU based on previous observations of efficacy against an oxidant pollutant in mice . At 24 hours after Cl2 exposure, lung function measurements including responsiveness to aerosolized MCh were performed and bronchoalveolar lavage fluid was obtained for assessment of inflammatory cell counts, total protein, nitrate/nitrite (nitric oxide) and glutathione levels. The lungs were removed for analysis of carbonylated proteins and 4-hydroxynonenal (4-HNE). Measurements of inflammatory cell counts and glutathione levels in BAL fluid were made also at 10 min and at 1 hr after Cl2. Following exposure animals were returned to the animal facility and allowed food and water ad libitum.
Exposure to Cl2
Mice were restrained and exposed to Cl2 gas for 5 minutes using a nose-only exposure device. Cl2 gas was mixed with room air using a standardized calibrator (VICI Metronics, Dynacalibrator®, model 230-28A). The Cl2 delivery system has two main components, a gas generator, which includes a heated permeation chamber and air flow generator. Dynacal permeation tubes designed specifically for operation with the Dynacalibrator were used and contain the Cl2. The permeation chamber and air flow generator control accuracy of the Cl2 generated to within 1-3% of the desired concentration (manufacturer's specifications). Within the gas chamber, permeation tubes containing Cl2 are housed for gas delivery. The Teflon permeation tubes contain Cl2 in both gas and liquid phases. When the tube is heated the Cl2 reaches a constant and increased vapor pressure and it permeates the tube at a constant rate. The desired concentration is delivered at an appropriate flow rate, as specified by the manufacturer. The device is attached to the exposure chamber and allowed to calibrate for 30 minutes until the optimum temperature of 30°C is reached and the Cl2 flow is constant. Following removal of the animals from the exposure chamber, the chamber was continually flushed with the gas mix to ensure that the desired concentration of Cl2 was maintained.
Evaluation of Respiratory Responsiveness
Mice were sedated with an intraperitoneal (i.p) injection of xylazine hydrochloride (8 mg/kg) and anaesthetized with i.p. injection of pentobarbital (30 mg/kg). Subsequently, the animal was tracheostomized using at 18 gauge cannula and connected to a small animal ventilator (FlexiVent, Scireq, Montreal, Canada). Muscle paralysis was induced with pancuronium bromide (0.2 mg/kg i.p.). The mice were ventilated in a quasi-sinusoidal fashion with the following settings: a tidal volume of 10 mL/kg, maximum inflation pressure of 30 cmH20, a positive end expiratory pressure (PEEP) of 3 cmH20 and a frequency of 150/min. Following an equilibration period of 3 minutes of tidal ventilation two lung inflations to a transrespiratory pressure of 25 cm H2O were performed and baseline measurements were taken. The respiratory mechanics were estimated using a single compartment model and commercial software (Scireq). Baseline was established as the average of three perturbations. Following establishment of baseline, MCh was administered using an in-line nebulizer (Aeroneb Lab, standard mist model, Aerogen Ltd, Ireland) and progressively doubling concentrations ranging from 6.25 to 50 mg/ml were administered over 10 seconds synchronously with inspiration. Six perturbations were calculated at each dose of MCh to establish the peak response. The highest value was kept for analysis subject to a coefficient of determination above 0.85. Respiratory system resistance (Rrs) and respiratory system elastance (Edyn) were determined before challenge and after each dose of MCh.
Bronchoalveolar Lavage Fluid Analysis
Following euthanasia (60 mg/kg pentabarbital, i.p.), the lungs were lavaged with 600 μl of sterile saline, followed by four separate aliquots of 1 ml each as previously described . The first 600 μlmL aliquot of BAL fluid was centrifuged at 1500 rpm for 5 minutes at 4°C and the supernatant was retained for measurements of nitric oxide, glutathione levels and protein levels using a Bradford Assay. The separate 1 mL aliquots were spun at 1500 rpm for 5 min at 4°C and the supernatant removed. The cell pellets were pooled for differential cell counts using 100 μl of the re-suspended cells. Cytospins were prepared, air-dried and stained (Diff-Quik® method, Medical Diagnostics, Düdingen, Germany). A differential cell count was determined on a minimum of 300 cells.
Following harvesting, the lungs were perfused with saline until the effluent was clear. The right lung was inflated with 1 mL 10% buffered formalin, fixed overnight with formalin. Tissues were embedded in paraffin blocks, cut into 5 μm sections and stained with hematoxylin and eosin. Sections were evaluated for epithelial morphological changes. The absolute number of epithelial cells in the airways was determined by counting cells on hematoxylin and eosin stained slides at 200× magnification and data were expressed as the number of epithelial cells per mm of basement membrane perimeter (PBM). Epithelial cell height was determined by measuring the distance between the basement membrane and the top of the epithelial cell in the four quadrants for each airway and averaged.
Measurement of Nitrite/Nitrate in BAL
For the evaluation of nitric oxide, 0.6 N trichloroacetic acid was added to the supernatant of the BAL fluid to give a final concentration of 0.12 N to precipitate any protein. Samples were centrifuged for 10 minutes at 10,000 RPM followed by removal of the supernatant for analysis using previously described methods . Total NOx was measured in BAL as an index of NO production using the Griess reaction. Briefly, 80 μl of sample were pre-incubated with 20 μl of NO3 reductase and 10 μl of its enzyme cofactor for 3 h at room temperature and then incubated with 100 μl of Griess reagent for 10 min. NOx concentrations were determined using standard curves obtained from different concentrations of NaNO2 or NaNO3. Absorbance was measured at 540 nm with a plate reader (SLT 400 ATC; SLT Lab Instruments, Salzburg, Austria). No NOx was detected in saline solutions using this assay.
Carbonylated protein residues (Oxyblot)
An Oxyblot was performed on left lung tissue extracts taken 24 hours following Cl2 challenge. Extracted proteins were denatured with 12% sodium dodecylsulfate (SDS) before derivatization with the addition of DNPH (2,4-dinitrophenylhydrazone-hydrazone). DNPH-derivatised proteins were separated on a 10% SDS-PAGE gel at 140 V for 2 h. Proteins were then electrophoretically transferred onto polyvinylidene difluoride (PVDF) membrane with 11.6 mM Tris (Fisher), 95.9 mM glycine (Fisher) and 20% methanol (Fisher) at 25 V for 2 h. Membranes were then blocked with 1% bovine serum albumin-TTBS solution (0.02 M Tris base, 0.5 M NaCl, and 0.1% of Tween 20; Sigma) and were probed for 90 min with rabbit anti-DNP antibody (Intergen Company, Purchase, NY). The membranes were then rinsed in TTBS and incubated with HRP-conjugated goat anti-rabbit IgG (Intergen Company, Purchase, NY) for 1 h. A chemiluminescence detection system (ECL Plus; Amersham), Hyperfilm (Amersham), and Fluorochem 8000 software (Alpha Innotech Corporation, San Leandro, CA) were used for antibody detection and quantification by densitometry.
Lung 4-hydroxynonenal (4-HNE) assay
All reagents were from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. Frozen tissue, or a known amount of 4- HNE standard (Cayman Chemical, Ann Arbor, MI, USA), was placed in 2 ml of cold methanol (Thermo Fisher) containing 50 μg/ml butylated hydroxytoluene, with 10 ng d3-4-HNE (Cayman Chemical) internal standard added just before homogenization with the Ultra-Turrax T25 (Thermo Fisher). An EDTA solution (1 ml of 0.2 M, pH 7) was added. Derivatization was accomplished by the addition of 0.2 ml of 0.1 M HEPES containing 50 mM O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine hydrochloride, pH 6.5. The mixture was then vortexed and held at room temperature. After 5 min, 1 ml of hexanes (Thermo Fisher) was added, and the samples were shaken vigorously. Brief centrifugation was performed to achieve phase separation and the O-pentafluorobenzyl-oxime derivatives were extracted from the upper hexane layer. The sample was dried under a stream of N2 gas and further derivatized into trimethylsilyl ethers by the addition of 15 μl each of pyridine and N, O bis(trimethylsilyl)trifluoroacetamide. The samples were vortexed and heated to 80°C for 5 min and then analyzed for 4-HNE content by GC/MS. GC/MS analysis was performed using a Focus GC coupled to a DSQ II mass spectrometer and an AS 3000 autosampler (Thermo Fisher).A15-m TR-5MS column (0.25-mm i.d., 0.25-μm film thickness; Thermo Fisher) was used with ultrahigh-purity helium as the carrier gas at a constant flow rate of 1.0 ml/min. Two microliters of sample was injected into the 270°C inlet using split mode with an injection ratio of 10 and a split flow of 10 ml/min. The initial oven temperature was 100°C and then ramped to 200°C at 15°C/min, followed by an increase in temperature to 300°C at 30°C/min, and held for 1 min. The MS transfer line temperature was held constant at 250°C and the quadrupole at 180°C. Analysis was done by negative-ion chemical ionization using 2.5 ml/min methane reagent gas. Ions were detected using SIM mode with a dwell time of 15.0 ms for each fragment of 4-HNE at m/z 152, 283, and 303, and d3-4-HNE at m/z 153, 286, and 306. Under these conditions, the larger, second peak of the two 4-HNE isomers was used for quantification and exhibited a retention time of 7.18 min, which was just preceded by the elution of d3-4-HNE at 7.17 min. Quantification was performed using a standard curve generated by graphing the area ratio of 4-HNE to d3-4-HNE versus concentration.
Measurement of glutathione (GSH and GSSG) in BAL fluid and cells
BAL fluid from control, chlorine exposed and DMTU pre-treated chlorine exposed mice was collected for glutathione evaluation by HPLC. Both glutathione (GSH) and glutathione disulfide (GSSG) were measured to determine if GSH had converted to GSSG. As GSH is found almost exclusively in its reduced form, a conversion to GSSG, which his inducible following oxidative stress, would indicate an increase in oxidative stress in the lung. BAL samples were collected at 10 minutes, one hour and 24 hours after Cl2 challenge. Phosphoric acid (60 μL; 1 M) was added to BALF samples to prevent GSH degradation. BAL was centrifuged at 1500 RPM for 5 minutes, and the supernatant was removed for evaluation of extracellular GSH/GSSG and 150 μL of PBS and 15 μL 1 M phosphoric acid added was used to reconstitute the pellet for analysis of intracellular GSH and GSSG. CHAPPS (150 μL; 6 mM) was added to lyse the cells. GSH and GSSG were measured by RP-HPLC using a post-column derivatization procedure modified from the literature . GSH and GSSG levels were determined in 50 μl aliquots by RP-HPLC using a gradient prepared from 0.05% trifluoroacetic acid (TFA) in water (solvent C) and 0.05% TFA in acetonitrile (solvent D) as follows: 0 min, 0% D; 10 min, 15% D. The flow rate was 1 ml/min and the stationery phase was a column (150 × 4.6 mm) of Ultracarb ODS (31% carbon loading; 5 μm particle size; 150 × 4.6 mm; Phenomenex, Torrance, CA). The eluate from the column was mixed with o-phthalaldehyde (370 μM) in 0.2 M tribasic sodium phosphate, pH 12, which was pumped into a T-fitting using an auxiliary pump (Waters Reagent Manager). The mixture then passed through a loop of PEEK tubing (6 m × 0.5 mm, i.d.; volume, 1.2 ml) that was placed in a water bath at 70°C. Under these conditions both GSH and GSSG are converted to a fluorescent isoindole adduct, which is measured using excitation and emission wavelengths of 336 and 420 nm, respectively. Prior to introduction into the fluorescence detector (Waters model 2475 Multi wavelength Fluorescence Detector), the mixture was cooled in a small ice-water bath and passed through a filter containing an OptiSolv 0.2 μm frit (Optimize Technologies). The amounts of GSH and GSSG were determined from a standard curve using the authentic compounds as external standards.
Data were analyzed using an analysis of variance and for post hoc comparisons of means a Newman-Keuls test was used. A p < 0.05 was accepted as significant. All values are expressed as the mean + one standard error of the mean.
Concentration-dependent changes in airway responsiveness following Cl2
Histological changes in the airways after Cl2exposure
Effect of DMTU on MCh responsiveness following Cl2challenge
Changes in bronchoalveolar lavage cells after Cl2gas exposure
Changes in protein level following Cl2exposure
Effects of Cl2on markers of oxidative stress
Effects of Cl2and DMTU treatments on GSH and GSSG intracellularly and extracellularly in the bronchoalveolar compartment
In the current study we have shown that Balb/C mice exposed to Cl2 gas for 5 min develop concentration-dependent airway hyperresponsiveness to inhaled aerosolized MCh. At concentrations of Cl2 greater than 100 ppm there is evidence of epithelial damage with flattening of the cells and the shedding of ciliated cells into the bronchoalveolar lavage fluid. However, at a concentration of Cl2 (100 ppm), despite the lack of gross morphological changes in epithelial cells there was still a substantial degree of airway hyperresponsiveness, an effect potentially attributable to increased oxidative stress. The effect of Cl2 on airway function was attenuated by pre-treating the mice one hour before Cl2 exposure with an intraperitoneal injection of DMTU. Treatment with DMTU 1 hour after exposure to Cl2 also ameliorated the adverse effects on airway function. Oxidative injury to lung tissue was detected 24 hours post-Cl2 exposure and indicated by and increase lipid peroxidation in Cl2 exposed mice, an effect attenuated by pre- or post-Cl2 treatment with DMTU. Additionally, DMTU treatment maintained GSH/GSSG levels at those of control mice, whereas Cl2 only treated mice showed significant changes in both GSH and GSSG at various time points.
Airway hyperresponsiveness has been previously demonstrated to follow Cl2 exposure in both rat and mouse models of irritant induced asthma [15, 16]. Pathological changes including airway remodeling occur following a single exposure to a high concentration of Cl2 in rats . It seems likely that epithelial damage is a major contributor to the altered responsiveness to inhaled MCh. The epithelium could serve as a barrier that could reduce access of MCh to the smooth muscle or might attenuate the responsiveness to MCh through the release of relaxant substances such as NO or prostaglandins [18–20]. The mechanism of AHR following Cl2 may be similar to that of ozone in that both forms of injury are associated with oxidant damage to the tissues. Natural killer cells and interleukin-17 have been shown recently to be essential in the protection against airway damage and hyperresponsiveness following repeated ozone exposures . Cl2 potentially causes toxicity through its highly reactive nature. However, it is also know to cause damage through the generation of hydrochloric acid (HCl). Indeed HCl has been shown to cause airway hyperresponsiveness in mice when administered into the airways, by mechanisms that have been suggested to relate to epithelial barrier function. However, it has been shown that HCl is much less toxic than Cl2 so it is likely that the effects of Cl2 induced oxidants are more likely to account for its adverse effects [22, 7].
Irrespective of the mechanism of Cl2 induced airway hyperresponsiveness, DMTU was highly effective in preventing its development when given either as a pre-treatment or as a rescue treatment. Assuming that the therapeutic effects of DMTU are indeed mediated by anti-oxidant properties, the data suggest that the initial direct oxidative stress caused by Cl2 is only part of the oxidative burden and that another source of reactive oxygen is important in the time period between 1 and 24 h following Cl2 exposure. For example, secondary activation of neutrophils, macrophages or epithelium and various chemokines, cytokines and growth factors they secrete could conceivably contribute to airway damage in a mechanism similar those shown for respiratory viral infection .
Measures of oxidant injury such as nitric oxide production, as reflected in BAL nitrates/nitrites, and protein carbonylation were not detectably different from control animals at 24 hours after Cl2 exposure, consistent with a relatively mild injury compared to previous results . However, presence of oxidative stress was apparent following assessment of lung tissue levels of 4-HNE, an indication of lipid peroxidation. 4-HNE levels were reduced to baseline by pre- and post-Cl2 treatment with DMTU, suggesting that lipid peroxidation is a prolonged effect of exposure to Cl2 further supporting the conclusion that the amelioration of markers of airway injury is likely mediated by anti-oxidant properties of DMTU.
Glutathione is an important endogenous antioxidant and changes in its intracellular and extracellular concentrations are expected following an oxidant challenge such as Cl2. Generally oxidant stress is noted to diminish GSH both intracellularly and extracellularly in the lung (reviewed in ) although glutathione increases as an adaptive response to oxidative stress associated for example with cigarette smoking or pulmonary infection [25, 26]. We found that Cl2 exposure induced rapid and transient changes in glutathione concentrations. Ten minutes following exposure there was a surge in both intra- and extra-cellular GSH levels in BAL, presumably attributable to GSH synthesis and export into the extracellular milieu. Additionally, Cl2 may induce lysis of pulmonary cells, especially epithelial cells which might also contribute to the large amount of extracellular GSH. Epithelial cells are known to contain high levels of GSH  and high doses of Cl2 have been shown to cause epithelial cell shedding and/or lysis. However the changes in GSH observed in the current experiment occurred in the absence of significant changes in epithelial cell counts in BAL fluid or in epithelial cell numbers enumerated in the airway walls themselves. The changes in GSH were transient and had resolved by 1 hour. The rapid rise in GSH was prevented by pre-treatment with DMTU prior to Cl2 exposure, suggesting a measure of relief against the effects of oxidative stress.
In addition to the early spike in GSH concentration in BAL cells and fluid, we also noted a significant increase in GSH in its oxidized form, glutathione disulfide (GSSG), both intra-and exrtacellularly at 10 minutes, presumably indicative of oxidative stress in the lung. These changes were abrogated by DMTU supporting the idea that the mechanism of protection was through neutralization of oxygen metabolites. Furthermore, the protection provided by delayed treatment with DMTU further suggests that delayed oxidative stress is also a significant contributor to the response to injury. By 1 and 24 hours, GSH levels were restored but GSSG levels showed a significant decrease in chlorine exposed groups. It is not clear what the significance of this finding is for airway function. Despite the GSSG levels being depleted at this time point, the ratio of GSH/GSSG was higher in chlorine exposed mice compared with controls and DMTU treated animals. The anti-oxidants ascorbic acid, desferroxamine and N-acetyl-L-cysteine have been show to ameliorate the injury caused by Cl2 in the rat . In these experiments there was evidence of depletion of GSH by Cl2, an observation that we have not confirmed. However the exposure in the rat was substantially greater (400 ppm for 30 minutes).
Consideration of oxidative stress as a target in irritant-induced asthma caused by potent oxidants is reasonable. However, oxidative stress-induced damage may also contribute to other forms of asthma. Asthmatic subjects manifest evidence of oxidative stress, as evidenced by a variety of changes including increased superoxide generation from leukocytes, increased total nitrites and nitrates, increased protein carbonyls, increased nitric oxide in exhaled breath condensate, increased lipid peroxidation products and decreased protein sulfhydryls in plasma . They also show increased superoxide dismutase activity in red blood cells, increased total blood glutathione, and decreased glutathione peroxidase activity in red blood cells and leukocytes. A recent epidemiological study of childhood asthma demonstrated significant decreases in glutathione and amino acid precursors of glutathione as well as various other components of both enzymatic and non-enzymatic endogenous antioxidant defense mechanisms . Thioredoxin, a reducing protein, may also inhibit experimental allergic asthma and airway remodeling .
In conclusion, exposure to modest levels of Cl2 (100 ppm) leads to an increase in airway responsiveness in mice. Mice exposed to Cl2 showed increases in total inflammatory cells, in particular neutrophils and lymphocytes. Despite lack of increases in nitrate/nitrite or carbonylated proteins, lipid peroxidation levels (4-HNE) were significantly higher in Cl2 exposed animals. Importantly, there was also evidence of a salutary treatment effect when DMTU was administered as late as 1 hour after the exposure to Cl2 suggesting that oxidative damage is an ongoing process following the initial injury. Treatment with anti-oxidants shortly after acute exposure to highly irritant oxidant substances such as Cl2 may have therapeutic utility.
Supported by grants from the Institut de recherche Robert-Sauvé en santé et en sécurité du travail and the Canadian Institutes of Health Research (MOP 77749).
The research is supported by the CounterACT program, National Institutes of health Office of the Director, and National Institute of Health Enviornmental Science, Grant number U4 ESO15678 (CWW, BJD, JGM, TM).
- Henneberger PK, Olin AC, Andersson E, Hagberg S, Toren K: The incidence of respiratory symptoms and diseases among pulp mill workers with peak exposures to ozone and other irritant gases. Chest. 2005, 128: 3028-10.1378/chest.128.4.3028.PubMedView ArticleGoogle Scholar
- Brooks SM, Weiss MA, Bernstein IL: Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985, 88: 376-10.1378/chest.88.3.376.PubMedView ArticleGoogle Scholar
- Deschamps D, Soler P, Rosenberg N, Baud F, Gervais P: Persistent Asthma After Inhalation of A Mixture of Sodium-Hypochlorite and Hydrochloric-Acid. Chest. 1994, 105: 1895-10.1378/chest.105.6.1895.PubMedView ArticleGoogle Scholar
- Van SD, Wenck MA, Belflower A, Drociuk D, Ferdinands J, Holguin F, Svendsen E, Bretous L, Jankelevich S, Gibson JJ, Garbe P, Moolenaar RL: Acute health effects after exposure to chlorine gas released after a train derailment. Am J Emerg Med. 2009, 27: 1-10.1016/j.ajem.2007.12.006.View ArticleGoogle Scholar
- Lemiere C, Malo JL, Boutet M: Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J. 1997, 10: 241-10.1183/09031936.97.10010241.PubMedView ArticleGoogle Scholar
- Jia Y, Xu L, Turner DJ, Martin JG: Endogenous nitric oxide contributes to strain-related differences in airway responsiveness in rats. J Appl Physiol. 1996, 80: 404-PubMedGoogle Scholar
- Martin JG, Campbell HR, Iijima H, Gautrin D, Malo JL, Eidelman DH, Hamid Q, Maghni K: Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med. 2003, 168: 568-10.1164/rccm.200201-021OC.PubMedView ArticleGoogle Scholar
- Cheek JM, Mcdonald RJ, Rapalyea L, Tarkington BK, Hyde DM: Neutrophils Enhance Removal of Ozone-Injured Alveolar Epithelial-Cells In-Vitro. American Journal of Physiology-Lung Cellular and Molecular Physiology. 1995, 13: L527-L535.Google Scholar
- Leustik M, Doran S, Bracher A, Williams S, Squadrito GL, Schoeb TR, Postlethwait E, Matalon S: Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants. Am J Physiol Lung Cell Mol Physiol. 2008, 295: L733-L743. 10.1152/ajplung.90240.2008.PubMedPubMed CentralView ArticleGoogle Scholar
- Jackson JH, White CW, Parker NB, Ryan JW, Repine JE: Dimethylthiourea consumption reflects H2O2 concentrations and severity of acute lung injury. J Appl Physiol. 1985, 59 (6): 1995-8.PubMedGoogle Scholar
- Day BJ, van Heeckeren AM, Min E, Velsor LW: Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect Immun. 2004, 72: 2045-10.1128/IAI.72.4.2045-2051.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Hamada K, Goldsmith CA, Kobzik L: Increased airway hyperresponsiveness and inflammation in a juvenile mouse model of asthma exposed to air-pollutant aerosol. Journal of Toxicology and Environmental Health-Part A. 1999, 58: 129-10.1080/009841099157340.PubMedView ArticleGoogle Scholar
- Parmentier C, Leroy P, Wellman M, Nicolas A: Determination of cellular thiols and glutathione-related enzyme activities: versatility of high-performance liquid chromatography-spectrofluorimetric detection. J Chromatogr B Biomed Sci Appl. 1998, 719: 37-10.1016/S0378-4347(98)00414-9.PubMedView ArticleGoogle Scholar
- Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, Dekruyff RH, Shore SA, Umetsu DT: Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med. 2008, 205: 385-10.1084/jem.20071507.PubMedPubMed CentralView ArticleGoogle Scholar
- Demnati R, Fraser R, Ghezzo H, Martin JG, Plaa G, Malo JL: Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats. Eur Respir J. 1998, 11: 922-10.1183/09031936.98.11040922.PubMedView ArticleGoogle Scholar
- Koohsari H, Tamaoka M, Campbell HR, Martin JG: The role of gamma delta T cells in airway epithelial injury and bronchial responsiveness after chlorine gas exposure in mice. Respir Res. 2007, 8: 21-10.1186/1465-9921-8-21.PubMedPubMed CentralView ArticleGoogle Scholar
- Demnati R, Fraser R, Plaa G, Malo JL: Histopathological effects of acute exposure to chlorine gas on Sprague-Dawley rat lungs. J Environ Pathol Toxicol Oncol. 1995, 14: 15-PubMedGoogle Scholar
- Jongejan R, De Jongste J, Raatgeep R, Stijnen T, Bonta I, Kerrebijn K: Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. Eur J Pharmacol. 1991, 203: 187-10.1016/0014-2999(91)90714-2.PubMedView ArticleGoogle Scholar
- Morrison KJ, Gao Y, Vanhoutte PM: Epithelial modulation of airway smooth muscle. [Review]. Am J Physiol. 1990, 258: L254-L262.PubMedGoogle Scholar
- Xie Z, Hakoda H, Ito Y: Airway epithelial cells regulate membrane potential, neurotransmission and muscle tone of the dog airway smooth muscle. J Physiol (Lond). 1992, 449: 619-View ArticleGoogle Scholar
- Cantin AM, North SL, Hubbard RC, Crystal RG: Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol. 1987, 63: 152-PubMedGoogle Scholar
- Rahman I, Macnee W: Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J. 2000, 16: 534-10.1034/j.1399-3003.2000.016003534.x.PubMedView ArticleGoogle Scholar
- Kariya C, Leitner H, Min E, van HC, van HA, Day BJ: A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration. Am J Physiol Lung Cell Mol Physiol. 2007, 292: L1590-L1597. 10.1152/ajplung.00365.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Allen GB, Leclair TR, von RJ, Larrabee YC, Cloutier ME, Irvin CG, Bates JHT: Acid aspiration-induced airways hyperresponsiveness in mice. J Appl Physiol. 2009, 107: 1763-70. 10.1152/japplphysiol.00572.2009.PubMedPubMed CentralView ArticleGoogle Scholar
- Fox RB: Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest. 1984, 74: 1456-10.1172/JCI111558.PubMedPubMed CentralView ArticleGoogle Scholar
- Wang SZ, Xu H, Wraith A, Bowden JJ, Alpers JH, Forsyth KD: Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur Respir J. 1998, 12: 612-10.1183/09031936.98.12030612.PubMedView ArticleGoogle Scholar
- Nadeem A, Chhabra SK, Masood A, Raj HG: Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol. 2003, 111: 72-10.1067/mai.2003.17.PubMedView ArticleGoogle Scholar
- Sackesen C, Ercan H, Dizdar E, Soyer O, Gumus P, Tosun BN, Buyuktuncer Z, Karabulut E, Besler T, Kalayci O: A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol. 2008, 122 (1): 78-85. 10.1016/j.jaci.2008.03.035.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.